Inno Force has been equipped with global product development and biomedical manufacturing capabilities, and it pushes the development and commercialization of new biomedical medicines. It provides R&D and production ability for partners (providing end-to-end production service (CDMO) for customers, including GMP commercial production of plasmid DNA, virus vector and cell therapy products), the risk management professional knowledge, product development guidance and equity investment.
Location: China, Gansu, Xiaoshan
Member count: 51-200
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | triwise | en.triwise... |
| - | Pan Lin In... | panlincap.... |
Mentions in press and media 6
| Date | Title | Description | Category | Author | Source |
| 02.12.2022 | Innoforce ... | The new site adds to its capac... | - | - | en.prnasia... |
| 06.12.2021 | Innoforce ... | HANGZHOU, China, Dec. 6, 2021 ... | - | - | en.prnasia... |
| 17.08.2021 | Innoforce ... | HANGZHOU, China and ROCKVILL... | - | - | prnewswire... |
| 17.08.2021 | Innoforce ... | HANGZHOU, China and ROCKVILLE,... | - | - | en.prnasia... |
| 08.06.2021 | Innoforce ... | HANGZHOU, China and ROCKVILLE,... | - | - | en.prnasia... |
| 08.06.2021 | Innoforce ... | HANGZHOU, China and ROCKVILL... | - | - | prnewswire... |